These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 630677)

  • 1. Clinical electrophysiologic effects of tocainide.
    Anderson JL; Mason JW; Winkle RA; Meffin PJ; Fowles RE; Peters L; Harrison DC
    Circulation; 1978 Apr; 57(4):685-91. PubMed ID: 630677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical electrophysiologic effects of encainide, a newly developed antiarrhythmic agent.
    Sami M; Mason JW; Peters F; Harrison DC
    Am J Cardiol; 1979 Sep; 44(3):526-32. PubMed ID: 474433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serial electrophysiologic effects of bretylium in man and their correlation with plasma concentrations.
    Anderson JL; Brodine WN; Patterson E; Marshall HW; Allison SD; Lucchesi BR
    J Cardiovasc Pharmacol; 1982; 4(6):871-82. PubMed ID: 6185777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human Electropharmacology of Tocainide, a lidocaine congener.
    Horowitz LN; Josephson ME; Farshidi A
    Am J Cardiol; 1978 Aug; 42(2):276-80. PubMed ID: 685840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrophysiologic effects of cibenzoline in humans related to dose and plasma concentration.
    Touboul P; Atallah G; Kirkorian G; de Zuloaga C; Dufour A; Aymard MF; Lavaud P; Moleur P
    Am Heart J; 1986 Aug; 112(2):333-9. PubMed ID: 3526853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrophysiology of oral encainide.
    Jackman WM; Zipes DP; Naccarelli GV; Rinkenberger RL; Heger JJ; Prystowsky EN
    Am J Cardiol; 1982 Apr; 49(5):1270-8. PubMed ID: 6801954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical electrophysiological effects of intravenous recainam: an antiarrhythmic drug under investigation for the treatment of ventricular and supraventricular arrhythmias.
    Feld GK; Luceri RM; Greenspon AJ; Singh BN; Horowitz LN; Capuzzi DM; Frame VB; Myerburg RJ
    Pacing Clin Electrophysiol; 1991 Jul; 14(7):1129-37. PubMed ID: 1715550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiarrhythmic effects of selective prolongation of refractoriness. Electrophysiologic actions of sematilide HCl in humans.
    Sager PT; Nademanee K; Antimisiaris M; Pacifico A; Pruitt C; Godfrey R; Singh BN
    Circulation; 1993 Sep; 88(3):1072-82. PubMed ID: 8353869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrophysiologic effects of N-acetylprocainamide in human beings.
    Jaillon P; Rubenson D; Peters F; Mason JW; Winkle RA
    Am J Cardiol; 1981 May; 47(5):1134-40. PubMed ID: 6164285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The direct electrophysiologic effects of disopyramide phosphate in the transplanted human heart.
    Bexton RS; Hellestrand KJ; Cory-Pearce R; Spurrell RA; English TA; Camm AJ
    Circulation; 1983 Jan; 67(1):38-45. PubMed ID: 6401173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Canine electrophysiology of encainide, a new antiarrhythmic drug.
    Sami M; Mason JW; Oh G; Harrison DC
    Am J Cardiol; 1979 Jun; 43(6):1149-54. PubMed ID: 443174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrophysiologic effects of intravenous E-4031, a novel class III antiarrhythmic agent, in patients with supraventricular tachyarrhythmias.
    Fujiki A; Tani M; Mizumaki K; Shimono M; Inoue H
    J Cardiovasc Pharmacol; 1994 Mar; 23(3):374-8. PubMed ID: 7515979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective effects of tocainide in canine acute myocardial infarction.
    Hiromasa S; Li ZY; Coto H; Maldonado C; Kupersmith J
    Int J Cardiol; 1990 Apr; 27(1):79-86. PubMed ID: 2110552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodynamic and electrophysiologic interactions between antiarrhythmic drugs and beta blockers, with special reference to tocainide.
    Ikram H
    Am Heart J; 1980 Dec; 100(6 Pt 2):1076-80. PubMed ID: 6108707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The hemodynamic effects of intravenous tocainide in patients with heart disease.
    Winkle RA; Anderson JL; Peters F; Meffin PJ; Fowles RE; Harrison DC
    Circulation; 1978 Apr; 57(4):787-92. PubMed ID: 630689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiarrhythmic efficacy, clinical electrophysiology, and pharmacokinetics of 3-methoxy-O-desmethyl encainide (MODE) in patients with inducible ventricular tachycardia or fibrillation.
    Roden DM; Lee JT; Woosley RL; Echt DS
    Circulation; 1989 Nov; 80(5):1247-58. PubMed ID: 2805262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Electrophysiologic effects of dopamine on the cardiac conduction system (author's transl)].
    Bischoff KO; Hager W; Bödeker K
    Z Kardiol; 1981 Sep; 70(9):643-51. PubMed ID: 7303803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrophysiologic effects of lidocaine in children.
    Shakibi JG; Aryanpur I
    Jpn Heart J; 1979 May; 20(3):271-6. PubMed ID: 459096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of magnesium sulfate on cardiac conduction and refractoriness in humans.
    DiCarlo LA; Morady F; de Buitleir M; Krol RB; Schurig L; Annesley TM
    J Am Coll Cardiol; 1986 Jun; 7(6):1356-62. PubMed ID: 3711493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Electrophysiologic effects of intravenous carocainide].
    Zannad F; Aliot E; Baille N; Gilgenkrantz JM
    Arch Mal Coeur Vaiss; 1986 Feb; 79(2):236-41. PubMed ID: 3085623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.